The managers of the National Medical Services Laboratories in Pennsylvania, USA, denied that Mohbad had undergone a toxicological test.
According to the Punch, the US laboratory failed to conduct any toxicology tests on site to determine the cause of singer Ilerioluwa Aloba, popularly known as Mohbad's, death.
Punch contacted NMS Labs about the examination, and NMS Labs responded with this comment.
A pathologist said during the May 15 Coroner's Court hearing that Mohbad's body decomposed, making an autopsy difficult to determine the cause of death.
When the Coroner's Court met again in the Ikorodu district in November 2023, state attorney O. Akinde told the court that the toxicology test—which is an essential step in the autopsy process to determine the cause of death—was not available.
Three affiliate centers are helping the state DNA and Forensic Centre, which is now handling the case, but their services are limited.
They won't claim they can't handle an emergency like the one we are currently experiencing, therefore.
Thus, during the live broadcast, Omotoso stated, "There are three of them in the US, and the one handling this particular one is the NMS in Pennsylvania, USA."
Punch revealed that an email asking if a toxicology test had been performed at their facility to determine Mohbad's cause of death had been sent to the previously stated lab.
at response to the letter dated May 17, Esther Dede, a Client Services Associate at NMS Labs' Forensics Division, refuted the state government's assertion that Mohbad's toxicology test was conducted in any of their locations.
"We are sorry, but we do not currently have a case for that patient.
In order to ensure adherence to HIPAA privacy regulations, authorization from the submitting agency is required.